Antibodies of the
IgE isotype play a predominant role in
immediate hypersensitivity reactions.
IL-4, a T cell-derived lymphokine that stimulates increased Ia expression by resting B cells and increased
IgG1 secretion by LPS-activated B cells in vitro, has also been shown to regulate in vitro and in vivo polyclonal
IgE responses. We report that large quantities of a purified anti-IL-4 mAb inhibit primary in vivo polyclonal
IgE responses by 99% in mice infected with Nippostrongylus brasiliensis or injected with
anti-IgD antibodies, and totally inhibit secondary Ag-specific
IgE responses to TNP-
keyhole limpet hemocyanin without effect on either
IgG1 or
IgG2a responses to these stimuli. The lack of effect of anti-IL-4 antibody on
IgG1 secretion cannot be explained simply by inadequate neutralization of
IL-4, inasmuch as the doses of anti-IL-4 antibody used blocked an N. brasiliensis-induced increase in B cell Ia expression by more than 85%, whereas in vitro studies indicate that enhancement of B cell Ia expression requires less
IL-4 than induction of
IgG1 secretion. In addition to demonstrating that
IL-4 plays a necessary role in the generation of an in vivo
IgE response, we show that
IL-4 has an important role in sustaining established
IgE responses, because anti-IL-4 antibody, when given at the peak of an N. brasiliensis- or TNP-
keyhole limpet hemocyanin-induced
IgE response, accelerates the declines in total serum
IgE and in
IgE anti-TNP antibody levels, respectively. These observations suggest that the effects of
IL-4 on in vivo immune responses may be more specific than might have been predicted from in vitro observations, and that regulation of
IL-4 production or action may be useful for the prevention or
therapy of
immediate hypersensitivity disorders.